NCT06971536View on ClinicalTrials.gov

Safety and Bioavailability of Micellar Green Tea Extract

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

December 10, 2023

Primary Completion Date

September 13, 2024

Study Completion Date

March 30, 2025

Conditions
Bioavailability and PharmacokineticsSafety
Interventions
DIETARY_SUPPLEMENT

Standard Green Tea

A maximum single dose of 300 mg green tea (hard gel capsules)

DIETARY_SUPPLEMENT

Phytosome Green Tea

A maximum single dose of 250 mg green tea (hard gel capsules)

DIETARY_SUPPLEMENT

LipoMicel Green Tea

A maximum single dose of 300 mg green tea (soft gel capsules)

Trial Locations (1)

Unknown

ISURA, Burnaby

All Listed Sponsors
lead

Isura

OTHER

NCT06971536 - Safety and Bioavailability of Micellar Green Tea Extract | Biotech Hunter | Biotech Hunter